Trial Profile
Effect of LY2216684 on Heart Rate and Blood Pressure in Healthy Subjects Receiving Oral Doses of Albuterol or Propranolol.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Edivoxetine (Primary) ; Propranolol; Salbutamol
- Indications Arrhythmias; Asthma; Attention-deficit hyperactivity disorder; Hypertension; Ischaemic heart disorders; Major depressive disorder; Migraine
- Focus Pharmacodynamics
- 28 Mar 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Mar 2011 NCT reports planned end date as (1 Mar 2011).
- 11 Mar 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.